WHO chief takes 'profit-driven' biopharma industry to task over Ebola failures
This article was originally published in SRA
Executive Summary
The head of the World Health Organization has criticized biopharmaceutical makers for being a "profit-driven industry" that "does not invest in products for markets that cannot pay," such as West Africa1. The WHO has in turn been accused of blaming the industry for its own failures.